Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
Transaction consideration provides a significant premium to the Appili shareholders
Combined enterprise expected to provide enhanced synergies and resources to advance key programs
Related news for (APLIF)
- Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc.
- Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
- Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia
- Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™
- Appili Therapeutics Seeks $117.5M in Funding and Provides Aditxt Deal Updates